Received Aug 26, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTPPVHBHPB | DTAP+IPV+HIB+HEPB (VAXELIS) | MSP VACCINE COMPANY | 4 | U7899AA | IM / LL |
| PNC20 | PNEUMO (PREVNAR20) | PFIZER\WYETH | UNK | — | — |
HCP reports no adverse events reaction to extra dose/no long term effects noted; Inadvertently administered extra dose of VAXELIS 3 weeks later, after third dose/vaxelis given too soon for schedule; Inadvertently administered extra dose of VAXELIS 3 weeks later, after third dose; This non-serious spontaneous, safety report with reference numbers: 02821253 and 02821250 was received by partner on 12-JUN-2025 and forwarded to RA on 12-JUN-2025 from a physician. The causal relationship between Vaxelis and the reported events; "Inadvertently administered extra dose of VAXELIS 3 weeks later, after third dose", and "HCP reports no adverse events reaction to extra dose" was assessed as not applicable due to the nature of the events. This case was considered off-label use due to patient receiving an extra dose (4th dose) of Vaxelis. Further information is expected. FOLLOW-UP INFORMATION with reference numbers: 02821253 was received by partner, on 05-Aug-2025 and forwarded to RA on 05-Aug-2025 from a physician. The case is maintained as non-serious and off-label. The causal relationship between Vaxelis and the reported events; "Inadvertently administered extra dose of VAXELIS 3 weeks later, after third dose", and "HCP reports no adverse events reaction to extra dose" was assessed as not applicable due to the nature of the events. No further information is expected
Prophylaxis
ROTATEQ